RR

Rakesh Roshan

Active Director Director DIN 10405719
DIN 10405719 First appointment Nov 2023 Primary industry Oil & Gas
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value •••• Premium profile

About Rakesh Roshan

Data last updated:

Rakesh Roshan is a Director at Vetbac Pharmaceuticals Private Limited (since 2023). The company operates in Oil & Gas. Vetbac Pharmaceuticals Private Limited reported revenue of ₹47.9 Lakh (FY 2024).

DIN 10405719
Primary Designation Director
Industry Oil & Gas
First Appointment 27 Nov 2023
Oldest Company Age 9 yrs
Largest company Vetbac Pharmaceuticals Private Limited · ₹47.9 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Nov 20232017₹47.9 Lakh (FY 2024)Active

Board colleagues of Rakesh Roshan

Directorship timeline

Open interactive timeline →
Vetbac Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rakesh Roshan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rakesh Roshan

Rakesh Roshan currently holds 1 directorship: Vetbac Pharmaceuticals Private Limited (Director, since 27 Nov 2023, revenue ₹47.9 Lakh (FY 2024)).

Rakesh Roshan was first appointed on 27 Nov 2023 as Director at Vetbac Pharmaceuticals Private Limited.

The current boards of Rakesh Roshan's companies include Pratima Pandey (Vetbac Pharmaceuticals Private Limited), Punam Kumari (Vetbac Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available